TP53 and breast cancer: Here, we identified deleterious variants in validated BC predisposition genes (ATM, CDH1, CHEK2, PALB2, and TP53) in 312 of 5589 BC index cases, enabling the offer of predictive testing and adjusted surveillance programs in these families.